TABLE 2.
RAPD patterns for the five variants
| Variant | Strain(s) | Additional amplified fragment generated witha:
|
||||
|---|---|---|---|---|---|---|
| Primer A1 | Primer A15 | Primer B10 | Primer B12 | Primer B18 | ||
| South Pacific | Australian strains Morgan, ORAM, MW4u, PA90, PA105, PA34, and PA117 | (−) | + | − | − | − |
| New Zealand strain NH1 | (−) | + | + | + | − | |
| Chooz | French strain Ch2-1-e13b | (−) | + | + | − | − |
| Cattenom | French strain Na1165b | (+) | + | + | − | + |
| Japanese strains J16(1)42E and J26(50)45E | (+)/(−)b | + | + | − | + | |
| Widespread | French strain G1-3-f18; United States strains 124 and Enterprise; Mexican strains RPE-1, PLC-2, RTW-4, RC-5, and EjI-SON | (−) | + | + | +c | − |
| Euro-American | French strain L2-1-d11; English strain MCM; United States strains CJ, SW1, SW2, TY, WM, EPA 988s-GP2, EPA 1020s-GP2, and EPA 1027w-GP2 | (−) | − | + | + | − |
a
+, additional amplified fragment present; −, additional amplified fragment absent; (+), strong amplified fragment present; (−), weak amplified fragment present.
b
Strongly and weakly amplified fragment observed in J16(1)42E and J26(50)45E, respectively.
c
A specific band in addition to the additional fragment was present.